For decades, cancer treatment has largely focused on finding a single breakthrough therapy capable o...
J-Pharma has built its pipeline around amino acid transporter (LAT1)-targeted therapies. What was the vision behind this...
RESILIA tissue has been positioned as a significant advancement in valve technology. How does RESILIA tissue differ from...
Asia's biopharmaceutical manufacturing sector is entering a new phase of growth, driven by expanding biologics pipelines...
Africa carries the majority of the global sickle cell disease burden, yet care across many health systems remains fragme...
The next generation of cell and gene therapies is pushing manufacturing beyond the limits of conventiona...
Exosomes are rapidly emerging as one of the most promising frontiers in regenerative medicine, offering the therapeutic ...
As BIO Asia–Taiwan 2026 brought the region’s biotechnology and healthcare ecosystem together in Taip...
Drug development is approaching a significant inflection point. Advances in induced pluripotent stem cells (iPSCs), orga...
Cell therapy is approaching a defining transition: from highly specialised science to a reproducible, scalable pharmaceu...
The pharmaceutical industry’s innovation equation is changing. Developing an entirely new molecu...
The global CDMO market is moving beyond the era when manufacturing capacity alone defined competitive ...
As BioSpectrum Asia reports on the ground from BIO Asia–Taiwan 2026, being held from July 15–19 in T...
As gene therapy moves from scientific promise towards a new phase of commercial maturity, manufacturing has emerged as o...
Advancing Clinical Development and Evidence Generation Clinical development is entering a new era where success depends...
As cell and gene therapies progress from promising research to commercial reality, manufacturing has emerged as ...
As antibody-drug conjugates (ADCs) transition from a promising therapeutic modality to a cornerstone of precision oncolo...
As antibody-drug conjugates (ADCs), bispecific antibodies and other advanced biologics redefine the global therapeutics ...
The rapid expansion of in vivo gene therapy is reshaping expectations for viral vector manufacturing, placing greater em...
ADCs continue to represent a major growth area for drug developers, with the market projected to reach $69B by 20291. As...
As biotech innovation accelerates, Asia emerges as an increasingly important hub, driv...
Research institutions generate groundbreaking discoveries every year, yet only a small fraction successfully reach patie...
Despite causing millions of serious infections and hundreds of thousands of deaths each year, fungal diseases continue t...
Cincinnati's life sciences ecosystem is gaining momentum through a unique combination of scientific excellence, collabor...
Oklahoma City's life sciences ambitions are increasingly centred on advanced manufacturing, collaboration, and long-term...
